Proteomic Evidence of Complement and Coagulation Pathway Dysregulation in Transfusion‐Dependent Thalassemia
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Advances in Hematology
- Vol. 2026 (1)
Abstract
Transfusion‐dependent thalassemia (TDT) is characterized by chronic hemolysis, ineffective erythropoiesis, and iron overload, resulting in persistent oxidative stress and systemic inflammation. Patients with TDT are also at increased risk of thromboembolic complications, suggesting disturbance of hemostatic and immune‐related pathways. However, the molecular links between hemolysis, complement‐associated pathways, and coagulation abnormalities remain incompletely defined. In this study, quantitative serum proteomics was used to identify differentially expressed proteins in patients with TDT compared with healthy controls. Pathway enrichment and network analyses demonstrated coordinated alterations in proteins associated with complement regulation, coagulation pathways, lipid transport, and regulatory mechanisms. Complement component C3 and prothrombin showed increased abundance, whereas several regulatory and heme‐scavenging proteins, including alpha‐2‐macroglobulin, hemopexin, and ceruloplasmin, were reduced in TDT patients. Selected proteins were further evaluated using ELISA validation, which supported the direction of the proteomic findings. Overall, these results identify a serum proteomic profile consistent with perturbation of complement and coagulation‐related pathways in TDT in the context of chronic hemolysis and oxidative stress. This system‐level view provides additional insight into thromboinflammatory mechanisms in TDT and supports further investigation of these pathways as potential biomarkers of disease severity.Keywords
Funding Information
- International Medical University (IMU-431/2019)
This publication has 24 references indexed in Scilit:
- P1455: THROMBOEMBOLIC EVENTS IN SPLENECTOMISED VERSUS NON-SPLENECTOMISED THALASSEMIA PATIENTS: A META-ANALYSIS OF OBSERVATIONAL STUDIESHemaSphere, 2023
- Pathogenic Mechanisms in Thalassemia IHematology/Oncology Clinics of North America, 2023
- GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemiaeJHaem, 2022
- The thrombotic spectrum of B-thalassemiaThrombosis Update, 2022
- Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemiaiScience, 2022
- Pre‐ and Post‐transfusion Complement Activation in Transfusion‐dependent β‐thalassaemiaHemaSphere, 2018
- Analysis of protein profiling studies of β‐thalassemia/Hb E diseaseProteomics – Clinical Applications, 2016
- The role of complement activation in thrombosis and hemolytic anemiasTransfusion and Apheresis Science, 2016
- Differential plasma proteome profiles of mild versus severe β-thalassemia/Hb EAnnals of Hematology, 2012
- Thalassemia and hypercoagulabilityBlood Reviews, 2008